Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11033605
Methods of promoting angiogenesis in tissue with fibromodulin
granted -
US 11034768
Methods for treating or preventing asthma by administering an IL-4R antagonist
granted -
US 11034757
Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature
granted -
EP 3831384
VERWENDUNG VON MASITINIB ZUR BEHANDLUNG VON EOSINOPHILEM ASTHMA
granted -
US 11026889
Polymeric drug delivery systems for treatment of disease
granted -
US 11026920
Use of NK-1 receptor antagonist serlopitant in pruritus
granted -
US 11026947
ALK2 inhibitors and methods for inhibiting BMP signaling
granted -
US 11026988
Traditional Chinese medicine composition and use thereof
granted -
US 11026997
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11027008
Recombinant mumps virus vaccine
granted -
US 11028050
Salts and polymorphs of a PDE4 inhibitor
granted -
US 11028129
Compositions for expanding regulatory T cells (Treg) populations, and treating and ameliorating autoimmune diseases and conditions
granted -
US 11028162
Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moieties
granted -
US 11026931
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11028144
Soluble glycoprotein V for treating thrombotic diseases
granted -
US 11028362
Decellularized human amniotic membrane for cell delivery, cell culture and inflammation prevention
granted -
US 11028412
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 11028369
Induced extended pluripotent stem cells, method of making and using
granted -
US 11028388
CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa
granted -
US 11028160
Treating refractory migraine
granted -
US 11028392
Compositions and methods for inhibiting expression of the ALAS1 gene
granted -
US 11028152
Single domain antibodies to Chikungunya virus
granted -
US 11026939
High dosage valbenazine formulation and compositions, methods, and kits related thereto
granted -
US 11028120
CD73 inhibitors
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.